Why This Topic Matters

Correctly identifying the appropriate molecular pathology code affects claims accuracy and helps avoid misclassification of germline hereditary cancer testing as a different panel category.

Article Sections

1. Clinical scenario and coding question

   Introduces the specimen type, testing method, and hereditary cancer screening context. Poses the central coding question about which molecular pathology code category is most appropriate.

2. Coding comparison and rationale

   Compares the service described with several hereditary cancer panel and targeted sequencing code categories. Explains the general reasons the article evaluates an unlisted molecular pathology code instead of other panel options.